NELLCOR PURITAN BENNETT IRELAND UNLIMITED COMPANY
Location
Founded
1989-05-15
Website
Risk Signals
8565 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Surgical and Medical Instruments and Apparatus), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about NELLCOR PURITAN BENNETT IRELAND UNLIMITED COMPANY
Live alerts from global media, monitored by Business Radar
2023-10-12 (elobservatodo.cl)
Chile unites in October to combat the Cerebrovascu Attack
The month of October brings with it an important awareness date: World Stroke Day (CVA), which has been celebrated every October 29 since 2008.
Read more
2020-03-29 (nytimes.com)
The U.S. Tried to Build a New Fleet of Ventilators. The Mission Failed.
As the coronavirus spreads, the collapse of the project helps explain America’s acute shortage.
Read more
2019-06-18 (medcitynews.com)
How Tandem Diabetes Care found its way back from near-bankruptcy - MedCity News
The San Diego-based company has is in the midst of one of the most precipitous turnarounds in the medical device industry and is well positioned to grow alongside the expanding insulin pump market.
Read more
2018-02-22 (massdevice.com)
B. Braun's Aesculap closes $17m Dextera Surgical bankruptcy buyout
Surgical instrument maker Dextera Surgical and B. Braun subsidiary Aesculap said yesterday that they closed the $17.3 million deal to buy Dextera out of Chapter 11 bankruptcy. Redwood City, Calif.- based Dextera, formerly known as Cardica, agreed to the buyout in December 2017.
Read more
2007-04-16 (informa.com)
Medtronic reorganization
Firm combines its vascular and cardiac surgery businesses on April 11 to support "the convergence of cardiovascular specialties focused on applying both surgical and minimally invasive approaches to patient care," says Scott Ward, head of the new business. The new entity, Medtronic CardioVascular,
Read more
(beckersspine.com)
Smith+Nephew records $5.5B in 2023 revenue
Discover the impressive growth of medtech company Smith+Nephew as they surpass $5 billion in 2023 revenue.
Read more
(beckersspine.com)
Aclarion announces $3M public offering
Aclarion, a company focused on spine pain diagnostics, listed a $3 million public offering, the company said Feb. 26.
Read more